Search results
AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer
Benzinga via Yahoo Finance· 2 years agoAstraZeneca plc (NASDAQ: AZN) and Merck & Co Inc (NYSE: MRK) announced long-term follow-up results...
EC approves Celltrion’s Omlyclo for allergic conditions
Pharmaceutical Technology via Yahoo Finance· 10 hours agoThe European Commission (EC) has approved Celltrion’s Omlyclo (CT-P39) - the first and only...
Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian Cancer
Investor's Business Daily· 1 year agoAstraZeneca said Wednesday a combination of its drugs Lynparza and Imfinzi met the goal of a study...
AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study
Benzinga via Yahoo Finance· 1 year agoAstraZeneca Plc (NASDAQ: AZN) announced topline data from a planned interim analysis of the DUO-O...
Merck & AstraZeneca Partnered Lynparza Fails In Late-Stage Colorectal Cancer Study
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) will stop for futility the Phase 3 LYNK-003 trial of Lynparza with or...
MEI Pharma, Inc. (NASDAQ:MEIP) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 8 months agoMEI Pharma, Inc. (NASDAQ:MEIP) Q4 2023 Earnings Call Transcript September 26, 2023 MEI Pharma, Inc....
Outlook's (OTLK) Shares Decline on CRL for Wet AMD Candidate
Zacks via Yahoo Finance· 9 months agoOutlook Therapeutics’ OTLK shares nosedived more than 80% on Aug 30, after receiving a complete...
What This News Means for Merck
Motley Fool· 2 years agoIn combination with Roche's (OTC: RHHBY) bevacizumab (Avastin), Merck's (NYSE: MRK) oncology medicine -- co-owned with AstraZeneca (NASDAQ: AZN) and...
Breakthrough as new treatment improves outcome for children with rare cancer
The Independent via Yahoo News· 4 months agoA new treatment for a rare form of children’s cancer – which combines anti-tumour drugs with...
The Zacks Analyst Blog Highlights J&J, AstraZeneca, Merck, Seagen and Pfizer
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – April 10, 2023 – Zacks.com announces the list of stocks featured...